2024-516626-63-00CompletedPhase 1
A clinical study of MK-4646 in healthy people (MK-4646-002)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 18 Nov 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 27 Sept 2024
- Start date
- 18 Nov 2024
- Lead sponsor
- Merck Sharp & Dohme LLC
- EU CT number
- 2024-516626-63-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 32
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Ziekenhuis Gent | Gent | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.